Nov 6, 4:30 PM ET
Jaguar Health stockholders approve all six proposals, including reverse split range
Jaguar Health held a special meeting of stockholders on November 6, 2026, and all six proposals were approved. The approvals cover a reverse stock split at a ratio between 1-for-2 and 1-for-150, to be set by the board, and a reduction in the floor price of an equity line agreement with C/M Capital from $16.50 to $1.10 per share. The reverse split was approved under the Votes Cast Standard but not under the Majority of Outstanding Standard, as the filing notes.
- Special meeting held November 6, 2026; 3,383,169 of 7,802,102 shares of common stock outstanding as of the September 15, 2026 record date were represented.
- Reverse stock split approved at a ratio of not less than 1-for-2 and not greater than 1-for-150; the board will set the exact ratio and announce it within one year.
- Reverse split vote was 3,551,428 for and 222,394 against, but not approved under the Majority of Outstanding Standard.
- ELOC Agreement floor price cut from $16.50 to $1.10 per share; 2,400,107 votes for and 158,386 against.